Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy.

M M Beyer

    Pediatric Clinics of North America
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Approximately 50% of patients with Type I diabetes mellitus develop uremia. Glomerular microvasculopathy is a major threat, necessitating a phased management plan for kidney disease progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Salvage of clotted jugular vein hemodialysis catheters.

    Nephron·1994
    Same author

    The mineral and mechanical properties of bone in chronic experimental diabetes.

    Journal of orthopaedic research : official publication of the Orthopaedic Research Society·1988
    Same author

    Variations of susceptibility to alloxan induced diabetes in the rabbit.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1987
    Same author

    Adverse impact of hypertension on diabetic recipients of transplanted kidneys.

    Hypertension (Dallas, Tex. : 1979)·1985
    Same author

    Posttransplant diabetes in kidney transplant recipients.

    American journal of nephrology·1985
    Same author

    Treatment of the uremic diabetic.

    Nephron·1985
    Same journal

    No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

    Pediatric clinics of North America·2026
    Same journal

    Telemedicine and Access to Pediatric Dermatology Care.

    Pediatric clinics of North America·2026
    Same journal

    Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

    Pediatric clinics of North America·2026
    Same journal

    Medical Photography's Power to Change Medical Care.

    Pediatric clinics of North America·2026
    Same journal

    Insurance Hurdles for Laser Authorization in Pediatric Patients.

    Pediatric clinics of North America·2026
    Same journal

    Controversies in Increasing the Pipeline for Pediatric Dermatology.

    Pediatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Endocrinology
    • Diabetology

    Background:

    • Type I diabetes mellitus (TIDM) is a chronic condition affecting millions globally.
    • A significant complication of TIDM is the development of uremia, a severe kidney condition.
    • Glomerular microvasculopathy represents a primary threat to the longevity of patients with TIDM.

    Purpose of the Study:

    • To discuss the implications of glomerular microvasculopathy in Type I diabetes mellitus.
    • To outline a comprehensive, phased management strategy for diabetic kidney disease.
    • To foster a shared understanding among patients, families, and healthcare teams regarding kidney disease progression and management.

    Main Methods:

    • Review of existing literature on diabetic nephropathy and uremia.

    Related Experiment Videos

  • Analysis of the pathophysiology of glomerular microvasculopathy.
  • Development of a structured, multi-phase approach to kidney disease management.

    • Main Results:

    • Glomerular microvasculopathy is a predictable and serious complication in Type I diabetes.
    • A phased management plan can address kidney disease progression effectively.
    • Improved patient and team understanding enhances care coordination.

    Conclusions:

    • Effective management of diabetic kidney disease requires a proactive, phased approach.
    • Understanding and addressing glomerular microvasculopathy is crucial for patient longevity.
    • Collaborative care models improve outcomes for patients with Type I diabetes and kidney disease.